Skip to main content
logo
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
12.79
+0.06 (0.47%)
At close: Nov 9, 2026, 4:00 PM EST
12.64
-0.15 (-1.15%)
After-hours: Nov 9, 2026, 7:35 PM EST

ADMA Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
182.41146.93197.67-28.24-65.9-71.65
Depreciation & Amortization
7.468.18.058.337.115.5
Other Amortization
0.790.720.952.592.41.9
Loss (Gain) From Sale of Assets
-7.930.010.110.180.430.22
Stock-Based Compensation
24.0620.0313.626.195.223.49
Other Operating Activities
3.614.21-83.1829.879.53-0.14
Change in Accounts Receivable
-31.55-108.43-22.58-11.9213.07-15.34
Change in Inventory
-69.45-36.232.67-9.63-38.56-43.19
Change in Accounts Payable
10.762.334.153.840.81.36
Change in Other Net Operating Assets
20.662.74-2.787.586.45.49
Operating Cash Flow
140.850.4118.678.8-59.51-112.37
Operating Cash Flow Growth
116.70%-57.53%1248.55%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.89-22.58-8.23-4.77-13.91-13.51
Sale of Property, Plant & Equipment
5-----
Sale (Purchase) of Intangibles
-0.31-0.32-0.35-0.21--
Other Investing Activities
11----
Investing Cash Flow
-2.2-21.89-8.58-4.98-13.91-13.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-105-135151.75-
Long-Term Debt Repaid
--105.94-60-158.6-100.04-0.03
Net Debt Issued (Repaid)
122.66-0.94-60-23.651.71-0.03
Issuance of Common Stock
1.062.987.491.164.82121.14
Repurchase of Common Stock
-199.14-41.49-4.97-1.42-2.9-0.06
Other Financing Activities
-0.01-4.58-0.83-15.08-4.78-
Financing Cash Flow
-75.43-44.02-58.3-38.99108.85121.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
63.17-15.5251.8-35.1735.43-4.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
132.9127.82110.454.03-73.42-125.88
Free Cash Flow Growth
226.36%-74.81%2641.28%---
Free Cash Flow Margin
25.60%5.45%25.90%1.56%-47.65%-155.52%
Free Cash Flow Per Share
0.570.110.470.02-0.37-0.90
Levered Free Cash Flow
90.26-18.1575.16-0.93-53.5-96.39
Unlevered Free Cash Flow
96.09-14.4382.9112.11-43.85-90.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.739.0810.6718.0513.8811.16
Cash Income Tax Paid
35.8719.689.39---
Change in Working Capital
-69.59-139.6-18.54-10.12-18.29-51.68
SEC Filings: 10-K · 10-Q